NDT Advance Access published online on February 13, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratoire de Chimie et Biochimie pharmacologiques et toxicologiques, CNRS UMR 8601, Université Paris 5, 45 rue des Saints Pères, 75270 Paris Cedex 06, France
* To whom correspondence should be addressed. Background. In haemodialysis (HD) patients, advanced oxidation protein products (AOPP) were previously ascribed to oxidized plasma proteins, resulting mainly from increased myeloperoxidase (MPO) activity. The aim of the present study was to assess the mechanisms leading to the generation of AOPP during the course of chronic kidney disease including end-stage renal disease, with particular focus on AOPP and MPO characterization in the plasma at decreasing levels of kidney function. Methods. Phagocyte activation was evaluated by whole blood NADPH oxidase and MPO activities. In plasma, MPO protein concentration was quantified by ELISA and catalytic activity assayed by the spectrophotometric detection of phenol and 4-aminoantipyrine (AAP) co-oxidation in the presence of hydrogen peroxide (H2O2). Results. In HD patients, plasma AOPP concentration was linked to neutrophil oxidative activity. Such an association was not found in control subjects or predialysis patients, suggesting that in the latter, AOPP generation did not mainly result from MPO released by activated neutrophils. Similarly, plasma AOPP correlated with plasma MPO protein concentration in HD patients, but not in control subjects or predialysis patients, suggesting that in the latter AOPP did not predominantly result from MPO activity. This interpretation was supported by the observation of a greater degree of co-oxidation of phenol and AAP in the absence of H2O2 in predialysis patients than in HD patients or control subjects. The contribution of MPO dramatically differed between predialysis and HD patients (2±5 vs 46±6%; P<0.001). Conclusion. Our observations suggest that AOPP generation in predialysis patients mainly results from MPO-independent oxidation mechanisms.
Received September 20, 2005
Accepted January 10, 2006
Original Article
Respective role of uraemic toxins and myeloperoxidase in the uraemic state
Chantal Capeillère-Blandin 1 *,
Valérie Gausson 2,
Anh Thu Nguyen 2,
Béatrice Descamps-Latscha 2,
Tilman Drüeke 2,
and
Véronique Witko-Sarsat 2
2 INSERM U507, Université Paris 5, Necker Hospital, Paris 75015, France
Chantal Capeillère-Blandin, E-mail: Chantal.Capeillere-Blandin{at}univ-paris5.fr
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Marsche, S. Frank, A. Hrzenjak, M. Holzer, S. Dirnberger, C. Wadsack, H. Scharnagl, T. Stojakovic, A. Heinemann, and K. Oettl Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo Circ. Res., March 27, 2009; 104(6): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brachemi, A. Mambole, F. Fakhouri, L. Mouthon, L. Guillevin, P. Lesavre, and L. Halbwachs-Mecarelli Increased Membrane Expression of Proteinase 3 during Neutrophil Adhesion in the Presence of Anti Proteinase 3 Antibodies J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2330 - 2339. [Abstract] [Full Text] [PDF]
|
|